Clonal CD8+ T-cell expansion is associated with complete response to elranatamab in refractory multiple myeloma
Roman Krzysiek,
Samuel Bitoun,
Rakiba Belkhir,
Salima Hacein-Bey-Abina,
Xavier Mariette
Affiliations
Roman Krzysiek
Clinical Immunology Laboratory, Groupe Hospitalier Universitaire Paris Saclay, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Le-Kremlin-Bicêtre, France; UMR 996 INSERM, Inflammation Microbiome and Immunosurveillance, Paris-Saclay University, Orsay
Samuel Bitoun
Department of Rheumatology, Université Paris Saclay, FHU CARE, INSERM UMR1184, APHP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; Paris-Saclay University, Faculty of Medicine, INSERM, Center for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin-Bicêtre
Rakiba Belkhir
Department of Rheumatology, Université Paris Saclay, FHU CARE, INSERM UMR1184, APHP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; Paris-Saclay University, Faculty of Medicine, INSERM, Center for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin-Bicêtre
Salima Hacein-Bey-Abina
Clinical Immunology Laboratory, Groupe Hospitalier Universitaire Paris Saclay, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Le-Kremlin-Bicêtre, France; Université Paris Cité, CNRS, INSERM, UTCBS, Unité des technologies Chimiques et Biologiques pour la Santé, Paris
Xavier Mariette
Department of Rheumatology, Université Paris Saclay, FHU CARE, INSERM UMR1184, APHP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; Paris-Saclay University, Faculty of Medicine, INSERM, Center for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin-Bicêtre
